Press-release for stocks related to license for AMRX

Prices are updated after-hours

Knight Therapeutics Enters into Exclusive License Agreement with Amneal Pharmaceuticals for IPX203
Published: 2024-01-25 (Crawled : 12:30) - globenewswire.com
AMRX | $6.07 12.41% 11.04% 3.1M

| -0.55% | O: 1.57% H: 0.73% C: -0.82%
ipx203 license pharmaceuticals therapeutics agreement

Amneal Announces U.S. FDA Filing Acceptance of Biologics License Application (BLA) for Bevacizumab
Published: 2021-06-17 (Crawled : 12:15) - biospace.com/
AMRX | $6.07 12.41% 11.04% 3.1M

| -6.41% | O: 0.52% H: 0.0% C: -4.14%
fda license application

62%

38%

CSSE 4 | $0.4323 183.85% 64.77% 220M

BOF | $1.99 70.09% 41.21% 110M

ILAG | $0.51 6.03% 40.62% 1.7M

LICN | $0.941 68.04% 40.49% 15M

AMST | $3.31 65.5% 39.58% 70M

MTC | $3.615 61.38% 38.04% 9.3M

WIMI | $1.15 58.53% 36.92% 19M

AIH | $0.45 12.5% 30.92% 320K

MULN | News | $3.78 38.46% 27.78% 13M

RILY | $29.86 37.48% 27.26% 12M

Save your searches and get alerts when important news are released.